Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Detailed study of imatinib metabolization using high-resolution mass spectrometry

D. Friedecký, K. Mičová, E. Faber, M. Hrdá, J. Široká, T. Adam,

. 2015 ; 1409 (-) : 173-81. [pub] 20150713

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NT12218 MZ0 CEP Register

Modern high resolution mass spectrometry offers unique identification capability in drug metabolism studies. In this work detailed imatinib metabolization in the plasma of patients with chronic myeloid leukemia is presented. The metabolites were separated by liquid chromatography on a C18 column with mass spectrometry detection via an Orbitrap Elite instrument (Thermo Scientific) based on exact mass measurement. A scan range of m/z 350-1200 resolution of 60,000 was applied (mass accuracy of 5ppm). The data were evaluated using the advanced software for mass spectrometry Mass Frontier and MetWorks. In all plasma samples, studied 90 metabolites in the concentration range of 0.0001-1μmol/L were identified by m/z values and confirmed by exact mass measurement of the MS(2) and MS(3) fragmentations. In order to achieve optimal clinical response and avoid toxicity, current therapeutic monitoring of parent drug is a useful tool for the individualization of treatment. Current high-resolution mass spectrometry possesses the potential to broaden this approach by monitoring number of potentially clinically relevant drug metabolites.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16000075
003      
CZ-PrNML
005      
20200121083636.0
007      
ta
008      
160108s2015 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.chroma.2015.07.033 $2 doi
035    __
$a (PubMed)26199102
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Friedecký, David $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic; Laboratory for Inherited Metabolic Disorders, Faculty of Medicine and Dentistry, Palacky University in Olomouc, University Hospital Olomouc, Czech Republic. Electronic address: david.friedecky@gmail.com. $7 xx0142900
245    10
$a Detailed study of imatinib metabolization using high-resolution mass spectrometry / $c D. Friedecký, K. Mičová, E. Faber, M. Hrdá, J. Široká, T. Adam,
520    9_
$a Modern high resolution mass spectrometry offers unique identification capability in drug metabolism studies. In this work detailed imatinib metabolization in the plasma of patients with chronic myeloid leukemia is presented. The metabolites were separated by liquid chromatography on a C18 column with mass spectrometry detection via an Orbitrap Elite instrument (Thermo Scientific) based on exact mass measurement. A scan range of m/z 350-1200 resolution of 60,000 was applied (mass accuracy of 5ppm). The data were evaluated using the advanced software for mass spectrometry Mass Frontier and MetWorks. In all plasma samples, studied 90 metabolites in the concentration range of 0.0001-1μmol/L were identified by m/z values and confirmed by exact mass measurement of the MS(2) and MS(3) fragmentations. In order to achieve optimal clinical response and avoid toxicity, current therapeutic monitoring of parent drug is a useful tool for the individualization of treatment. Current high-resolution mass spectrometry possesses the potential to broaden this approach by monitoring number of potentially clinically relevant drug metabolites.
650    _2
$a protinádorové látky $x krev $x terapeutické užití $7 D000970
650    _2
$a chromatografie kapalinová $x metody $7 D002853
650    _2
$a lidé $7 D006801
650    _2
$a imatinib mesylát $x krev $x terapeutické užití $7 D000068877
650    _2
$a chronická myeloidní leukemie $x krev $x farmakoterapie $7 D015464
650    _2
$a hmotnostní spektrometrie $x metody $7 D013058
650    _2
$a molekulová hmotnost $7 D008970
650    _2
$a software $7 D012984
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mičová, Kateřina $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic; Laboratory for Inherited Metabolic Disorders, Faculty of Medicine and Dentistry, Palacky University in Olomouc, University Hospital Olomouc, Czech Republic. $7 xx0260706
700    1_
$a Faber, Edgar, $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University in Olomouc, University Hospital Olomouc, Czech Republic. $d 1956- $7 xx0062699
700    1_
$a Hrdá, Marcela $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic.
700    1_
$a Široká, Jitka $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic.
700    1_
$a Adam, Tomáš, $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Czech Republic; Laboratory for Inherited Metabolic Disorders, Faculty of Medicine and Dentistry, Palacky University in Olomouc, University Hospital Olomouc, Czech Republic; Department of Clinical Chemistry, University Hospital Olomouc, Czech Republic. $d 1965- $7 xx0054162
773    0_
$w MED00004962 $t Journal of chromatography. A $x 1873-3778 $g Roč. 1409, č. - (2015), s. 173-81
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26199102 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160108 $b ABA008
991    __
$a 20200121084013 $b ABA008
999    __
$a ok $b bmc $g 1102356 $s 924281
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 1409 $c - $d 173-81 $e 20150713 $i 1873-3778 $m Journal of chromatography. A, Including electrophoresis and other separation methods $n J Chromatogr A $x MED00004962
GRA    __
$a NT12218 $p MZ0
LZP    __
$a Pubmed-20160108

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...